Stay updated with the latest blog posts and engage with our community
Elian V et al
HOFFMANN-LA ROCHE LTD: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022APRIL 2025 TABLE 1263 PFIZER INC.: COMPANY OVERVIEW TABLE 1264 PFIZER INC.: PRODUCTS OFFERED TABLE 1265 PFIZER INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022APRIL 2025 TABLE 1266 PFIZER INC.: DEALS, JANUARY 2022APRIL 2025 TABLE 1267 MERCK & CO., INC.: COMPANY OVERVIEW TABLE 1268 MERCK & CO., INC.: PRODUCTS OFFERED TABLE 1269 MERCK & CO., INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022APRIL 2025 TABLE 1270 MERCK & CO., INC.: DEALS, JANUARY 2022APRIL 2025 TABLE 1271 MERCK & CO., INC.: EXPANSIONS, JANUARY 2022APRIL 2025 TABLE 1272 NOVARTIS AG: COMPANY OVERVIEW TABLE 1273 NOVARTIS AG: PRODUCTS OFFERED TABLE 1274 NOVARTIS AG: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022APRIL 2025 TABLE 1275 NOVARTIS AG: DEALS, JANUARY 2022APRIL 2025 TABLE 1276 NOVARTIS AG: EXPANSIONS, JANUARY 2022APRIL 2025 TABLE 1277 BAYER AG: COMPANY OVERVIEW TABLE 1278 BAYER AG: PRODUCTS OFFERED TABLE 1279 BAYER AG: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022APRIL 2025 TABLE 1280 BAYER AG: EXPANSIONS, JANUARY 2022APRIL 2025 TABLE 1281 ASTRAZENECA: COMPANY OVERVIEW TABLE 1282 ASTRAZENECA: PRODUCTS OFFERED TABLE 1283 ASTRAZENECA: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022APRIL 2025 TABLE 1284 ASTRAZENECA: DEALS, JANUARY 2022APRIL 2025 TABLE 1285 ASTRAZENECA: EXPANSIONS, JANUARY 2022APRIL 2025 TABLE 1286 TAKEDA PHARMACEUTICAL COMPANY LIMITED: COMPANY OVERVIEW TABLE 1287 TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCTS OFFERED TABLE 1288 TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022APRIL 2025 TABLE 1289 TAKEDA PHARMACEUTICAL COMPANY LIMITED: DEALS, JANUARY 2022APRIL 2025 TABLE 1290 TAKEDA PHARMACEUTICAL COMPANY LIMITED: EXPANSIONS, JANUARY 2022APRIL 2025 TABLE 1291 ELI LILLY AND COMPANY: COMPANY OVERVIEW TABLE 1292 ELI LILLY AND COMPANY: PRODUCTS OFFERED TABLE 1293 ELI LILLY AND COMPANY: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022APRIL 2025 TABLE 1294 ELI LILLY AND COMPANY: EXPANSIONS, JANUARY 2022APRIL 2025 TABLE 1295 AMGEN INC.: COMPANY OVERVIEW TABLE 1296 AMGEN INC.: PRODUCTS OFFERED TABLE 1297 AMGEN INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022APRIL 2025 TABLE 1298 AMGEN INC.: DEALS, JANUARY 2022APRIL 2025 TABLE 1299 AMGEN INC.: EXPANSIONS, JANUARY 2022APRIL 2025 TABLE 1300 NOVO NORDISK A/S: COMPANY OVERVIEW TABLE 1301 NOVO NORDISK A/S: PRODUCTS OFFERED TABLE 1302 NOVO NORDISK A/S: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022APRIL 2025 TABLE 1303 NOVO NORDISK A/S: DEALS, JANUARY 2022APRIL 2025 TABLE 1304 NOVO NORDISK A/S: EXPANSIONS, JANUARY 2022APRIL 2025 TABLE 1305 REGENERON PHARMACEUTICALS INC.: COMPANY OVERVIEW TABLE 1306 REGENERON PHARMACEUTICALS INC.: PRODUCTS OFFERED TABLE 1307 REGENERON PHARMACEUTICALS INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022APRIL 2025 TABLE 1308 REGENERON PHARMACEUTICALS INC.: DEALS, JANUARY 2022APRIL 2025 TABLE 1309 FRESENIUS KABI AG: COMPANY OVERVIEW TABLE 1310 FRESENIUS KABI AG: PRODUCTS OFFERED TABLE 1311 FRESENIUS KABI AG: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022APRIL 2025 TABLE 1312 UCB S.A.: COMPANY OVERVIEW TABLE 1313 UCB S.A.: PRODUCTS OFFERED TABLE 1314 UCB S.A.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022APRIL 2025 TABLE 1315 BIO-THERA SOLUTIONS, LTD.: COMPANY OVERVIEW TABLE 1316 BIO-THERA SOLUTIONS, LTD.: PRODUCTS OFFERED TABLE 1317 BIO-THERA SOLUTIONS, LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022APRIL 2025 TABLE 1318 SAGENT: COMPANY OVERVIEW TABLE 1319 VALNEVA SE: COMPANY OVERVIEW TABLE 1320 XERIS PHARMACEUTICALS, INC.: COMPANY OVERVIEW TABLE 1321 PHARMAESSENTIA CORPORATION: COMPANY OVERVIEW TABLE 1322 HERON THERAPEUTICS, INC.: COMPANY OVERVIEW FIGURE 1 INJECTABLE DRUG DELIVERY MARKET SEGMENTATION FIGURE 2 INJECTABLE DRUG DELIVERY MARKET REGIONAL SEGMENTATION FIGURE 3 INJECTABLE DRUG DELIVERY MARKET: RESEARCH DESIGN FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION FIGURE 7 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS FIGURE 8 INJECTABLE DRUG DELIVERY MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH FIGURE 9 TOP-DOWN APPROACH FIGURE 10 BOTTOM-UP APPROACH FIGURE 11 DATA TRIANGULATION METHODOLOGY FIGURE 12 INJECTABLE DRUG DELIVERY MARKET, BY PRODUCT, 2025 VS
Heres how they create a synergy that enhances your immune protection: Antioxidant Recycling: When vitamin C neutralizes free radicals, it becomes oxidized and loses its antioxidant power
